| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062852A1 Receptor protein expressed on cells |
| 08/15/2002 | WO2002062846A2 Method and apparatus for the production of antigens and uses thereof |
| 08/15/2002 | WO2002062843A2 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | WO2002062842A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062833A2 Modified leptin with reduced immunogenicity |
| 08/15/2002 | WO2002062825A2 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 08/15/2002 | WO2002062418A1 Electromagnetic set for , diagnostic, preventive, therapeutic purposes |
| 08/15/2002 | WO2002062383A2 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases |
| 08/15/2002 | WO2002062375A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | WO2002062370A2 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 08/15/2002 | WO2002051871A3 Anti-cd28 antibody |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2001096875A9 Hcv antigen/antibody combination assay |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | WO2001085977A3 Chemoenzymatic synthesis of neotame |
| 08/15/2002 | WO2001081551A9 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111331 FGF-affinity chromatography |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020110913 Human cell culture for use in the generation of erythropoietin |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110873 Process for the production of lipstatin and tetrahydrolipstatin |
| 08/15/2002 | US20020110872 Cytotoxic factors for modulating cell death |
| 08/15/2002 | US20020110871 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110869 Polynucleotide encoding chimeric protein and related vector, cell and method of expression thereof |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110860 Chimeric polypeptides for use as gene expression tool in genetic engineering |
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | CA2476235A1 Electromagnetic assembly for diagnostic, preventive and therapeutic purposes |
| 08/15/2002 | CA2438376A1 Method and apparatus for the production of antigens and uses thereof |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437503A1 Hepatitis b virus treatment |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437484A1 Ragweed allergens |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2436986A1 Ter sites and ter binding proteins |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231279A1 Process for producing tripeptides |
| 08/14/2002 | EP1231278A1 Cell-free method for preparing post-translational modified proteins |
| 08/14/2002 | EP1231276A1 Method for purifying proteins and/or biomolecule of protein complexes |
| 08/14/2002 | EP1231275A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1231268A2 Polyclonal antibody libraries |
| 08/14/2002 | EP1231217A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230551A2 Methods to identify compounds that modulate neuronal activity |
| 08/14/2002 | EP1230379A2 Regulating endogenous inhibitor at atp synthase |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230271A1 Hedgehog fusion proteins and uses |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229795A2 Human chemokine beta-13 |
| 08/14/2002 | EP1187591A4 Ibd-associated microbial antigens and methods of using same |
| 08/14/2002 | EP0959898A4 Lactoferrin variants and uses thereof |
| 08/14/2002 | EP0954329B1 Method of killing target cells in harvested cell populations with two immunotoxins |
| 08/14/2002 | EP0868526B1 PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2 |
| 08/14/2002 | EP0806964B1 Chemical compounds |
| 08/14/2002 | EP0748335B1 Antibiotic stalobacins |
| 08/14/2002 | EP0554389B2 Molecular clones of hiv-1 and uses thereof |
| 08/14/2002 | DE10104722A1 Verfahren zur fermentativen Herstellung von Cystein, Cystin und Glutathion A process for the fermentative production of cysteine, cystine and glutathione |
| 08/14/2002 | CN1364172A Transcriptional activation inhibitory protein |
| 08/14/2002 | CN1363654A Genetically engineered bacteria and process for preparing insulinotropic hormone secretion peptide GLP-1 (7-36) |
| 08/14/2002 | CN1363609A Polypeptide-human ribosomal protein 18.91 and polynucleotide for coding it |
| 08/14/2002 | CN1363608A Polypeptide-ribosomal protein S19-35.53 and polynucleotide for coding it |
| 08/14/2002 | CN1363607A Polypeptide-mutine transient receptor potential protein 2 (Trp 2) 11.88 and polynucleotide for coding it |